EMBO Molecular Medicine · 2022 · 13 citations · 61 references
Life SciencesImmunologyPathologyCell TherapyImmunotherapyInflammationCell-based ImmunotherapyCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesEffector T Cell FunctionT Cell ActivationT Cell BiologyDifferentiationPredictive Biomarker AssessmentPredictive Biomarker DevelopmentRescueT Cell CytotoxicityT Cell-based ImmunotherapyT Cell-mediated CytotoxicityT-cell Therapy
Primary hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome caused by impaired lymphocyte cytotoxicity. First-line therapeutic regimens directed against activated immune cells or secreted cytokines show limited efficacy since they do not target the underlying immunological problem: defective lymphocyte cytotoxicity causing prolonged immune stimulation. A potential rescue strategy would be the adoptive transfer of ex vivo gene-corrected autologous T cells. However, transfusion of cytotoxicity-competent T cells under conditions of hyperinflammation may cause more harm than benefit. As a proof-of-concept for adoptive T cell therapy (ATCT) under hyperinflammatory conditions, we transferred syngeneic, cytotoxicity-competent T cells into mice with virally triggered active primary HLH. ATCT with functional syngeneic trigger-specific T cells cured Jinx mice from active HLH without life-threatening side effects and protected Perforin-deficient mice from lethal HLH progression by reconstituting cytotoxicity. Cured mice were protected long-term from HLH relapses. A threshold frequency of transferred T cells with functional differentiation was identified as a predictive biomarker for long-term survival. This study is the first proof-of-concept for ATCT in active HLH.
61
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan‐Inge Henter, AnnaCarin Horne, Maurizio Aricò et al. · Pediatric Blood & Cancer · 2006 · 5.3K citations
Medicine, Hematology, Immunology +17
David Kägi, Birgit Ledermann, Kurt Bürki et al. · Nature · 1994 · 1.8K citations
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
David Kägi, Françoise Vignaux, Birgit Ledermann et al. · Science · 1994 · 1.5K citations